Mothers who gained more weight during pregnancy had heavier infants and mothers who lost weight during pregnancy had lighter infants. Mothers who gained less weight (particularly <15 pounds) and who lost weight during their pregnancy had increased risk of a...
Across their pregnancies, mothers had an average of 12 weight measurements, allowing us to construct a longitudinal ‘journey’ of their weight change. Mothers gained an average of 31 pounds across their pregnancies and 45% of mothers had evidence of some weight loss....
Infections remain one of the most concerning complications following ureteroscopy (URS), a common procedure to examine or treat kidney stones. Even though URS is considered a safe and routine procedure, postoperative infections can lead to serious outcomes, including...
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most serious infections, often leading healthcare providers to start powerful, broad-spectrum antibiotics like intravenous (IV) vancomycin. While vancomycin can be life-saving, unnecessary use...
Medical device manufacturers and regulators face a persistent challenge: obtaining a complete, clinically rich view of how devices are used, how safe they are, and how they affect patient outcomes. Historically, researchers have been limited to claims, chargemaster,...
Today marks the 5 year anniversary of Truveta. I personally am so humbled by where we are today. As I reflect back to where we were in 2020, the world was a very different place. It was a time of great uncertainty. The world was desperate for answers to a pandemic...
Continuous glucose monitoring (CGM) is increasingly recognized not only for its role in diabetes management but also for its potential impact on broader health outcomes. A recent consensus statement highlighted the need for additional evidence on CGM use in people...
Gestational diabetes is one of the most common complications of pregnancy, affecting roughly 5–9% of pregnancies in the United States. When diagnosed and managed early, patients can avoid complications such as high birth weight, preterm delivery, or cesarean section....
Non–small cell lung cancer (NSCLC) accounts for about 85% of lung cancer cases and remains the leading cause of cancer death worldwide. While major advances in targeted therapies and immunotherapies have transformed care, gaps persist in biomarker testing, treatment...
At Johns Hopkins University, the Hopkins Business of Health Initiative (HBHI) has launched the HBHI–Truveta User Community, dedicated to fostering a collaborative group of researchers who use Truveta Data to drive cutting-edge research in health and healthcare. Led by...
In July 2025, following the CVS formulary change, 9.6% of patients on AOM tirzepatide switched to a different drug. This was more than a 16-fold increase compared with the average earlier in the year. Among AOM tirzepatide users who switched to a different GLP-1...
